drugset / Trial / NCT00220233

Olmesartan as an add-on to Amlodipine in Hypertension

NCT00220233

Phase 3 Completed 632 enrolled Sankyo Pharma Gmbh
RandomizedParallel-groupOpen-labelTreatment

Summary

This study is to test the efficacy and safety of the combination of olmesartan and amlodipine in hypertensive patients whose blood pressure is not adequately controlled with amlodipine alone

Timeline

Start
2005-04
Primary completion
Completion
2007-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Olmesartan medoxomil Unknown
Background Amlodipine Other / unclassified
Background Hydrochlorothiazide Unknown